---
title: "Cardiovascular Risk Screening Before US Antarctic Deployment: Comparing PREVENT, PCE, and FRS"
id: "medrxiv-12-pre-deployment-cardiovascular-risk-assessment-and-outcomes-among-united-states"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-12-pre-deployment-cardiovascular-risk-assessment-and-outcomes-among-united-states"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.14.26365580v1?rss=1"
published_at: "2026-10-16T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cardiovascular Risk Screening Before US Antarctic Deployment: Comparing PREVENT, PCE, and FRS
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-12-pre-deployment-cardiovascular-risk-assessment-and-outcomes-among-united-states
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.14.26365580v1?rss=1)
- **Published At:** 2026-10-16T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators retrospectively reviewed 154 individuals referred for enhanced cardiovascular evaluation before deployment to the US Antarctic Program; data were collected across three temporal cohorts (2018–2020, 2021–2023, 2024–2026). - The cohort was predominantly male (79.9%) with mean age 44.6 ± 14.6 years; the most common reason for referral was an abnormal ECG (70.8%). - The team calculated three risk estimates: Framingham Risk Score (**FRS**), AHA/ACC Pooled Cohort Equations (**PCE**), and **AHA PREVENT** models; PCE could be calculated in 52.6% of participants versus 70.8% for PREVENT. - Median 10-year risks differed by calculator: PREVENT 2.7% (IQR 1.1–6.6), FRS 2.3% (IQR 0.5–7.1), PCE 6.1% (IQR 2.4–9.2); PCE consistently estimated higher risk than PREVENT and FRS. - Among 72 participants with all three scores, investigators observed 51% discordant classifications; PREVENT correlated closely with FRS (correlation = 0.77) but poorly with PCE (correlation 0.24–0.35). - Deployment clearance outcomes: 132 (85.7%) were cleared, 8 (5.2%) were not physically qualified (NPQ); six NPQs were for cardiovascular reasons. - During the study period there were 22 cardiac evacuations; 21 involved people without prior advanced cardiovascular screening, while one screened individual underwent evacuation later found noncardiac. - The authors recommend **PREVENT** as the primary risk-stratification tool for this population, citing contemporary derivation, renal function incorporation, race-agnostic design, heart-failure risk coverage, applicability from age 30, and concordance with FRS. - The source did not report specific screening algorithms for how to integrate coronary artery calcium testing, nor did it provide prospective outcome validation against hard endpoints beyond evacuation counts. - The study received IRB approval (University of Texas Medical Branch, protocol 25-0347); data are available from the corresponding author upon reasonable request but are not publicly shared because of privacy protections.
## Clinical Analysis & Structured Key Points
Pre-Deployment Cardiovascular Risk Assessment and Outcomes among United States Antarctic Program Participants: Insights from Contemporary Risk Models | medRxiv Skip to main content Pre-Deployment Cardiovascular Risk Assessment and Outcomes among United States Antarctic Program Participants: Insights from Contemporary Risk Models Daniel Paul LeBlanc , View ORCID Profile Abdul Qadeer , View ORCID Profile Shiva Raju Gollapally Krishna , Andrew Forrester , Anjni Patel , Daniel Shi , Eric Nagueh , Jeremy Hsu , Neel Bhobe , View ORCID Profile Diann E. Gaalema , James McKeith , View ORCID Profile Hani Jneid , Joseph Allencherril doi: https://doi.org/10.64898/2026.10.14.26365580 Daniel Paul LeBlanc 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: dpleblan{at}utmb.edu Abdul Qadeer 2 The University of Texas Medical Branch, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Abdul Qadeer Shiva Raju Gollapally Krishna 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Shiva Raju Gollapally Krishna Andrew Forrester 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anjni Patel 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel Shi 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eric Nagueh 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jeremy Hsu 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Neel Bhobe 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Diann E. Gaalema 3 The University of Texas Medical Branch at Galveston Moody Medical Library, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Diann E. Gaalema James McKeith 1 The University of Texas Medical Branch at Galveston, UNITED STATES; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hani Jneid 4 University of Texas Medical Branch, UNITED STATES Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hani Jneid Joseph Allencherril 4 University of Texas Medical Branch, UNITED STATES Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: Cardiovascular (CV) screening is critical for personnel deploying to Antarctica, where geographic isolation and limited medical care make the management of acute cardiovascular events challenging. The utility of contemporary risk prediction tools such as the AHA PREVENT equations in this unique population remains uncertain. Methods: We retrospectively analyzed 154 individuals referred for enhanced CV evaluation before deployment to the U.S. Antarctic Program (USAP). Participants were evaluated across three temporal cohorts (2018-2020, 2021-2023, and 2024-2026). Demographics, CV risk factors, cardiac testing, and deployment clearance outcomes were collected. Risk was estimated using the Framingham Risk Score (FRS), AHA/ACC Pooled Cohort Equations (PCE), and AHA PREVENT risk models. Results: The cohort was predominantly male (79.9%; mean age 44.6 ± 14.6 years), and abnormal ECG was the most common referral trigger (70.8%). Median 10-year risk was low by PREVENT and FRS and borderline elevated by PCE (PREVENT 2.7% [IQR 1.1-6.6], FRS 2.3% [IQR 0.5-7.1], and PCE 6.1% [IQR 2.4-9.2]). Among 72 participants with all scores, 51% were classified discordantly; PREVENT ASCVD agreed closely with FRS (=0.77) but poorly with PCE (=0.24-0.35), which consistently estimated higher risk. PCE was calculable in 52.6% versus 70.8% for PREVENT. Overall, 132 participants (85.7%) were cleared for deployment, while 8 (5.2%) were not physically qualified (NPQ); 6 of these NPQs were due to cardiovascular causes. Of 22 cardiac medical evacuations during the study period, 21 involved individuals without prior advanced cardiovascular screening. One screened individual was evacuated for symptoms subsequently found to have no cardiac cause. Conclusions: Risk calculators disagree substantially in the fitness-selected population. We recommend PREVENT as the primary risk-stratification tool as it is the most contemporary derivation, incorporates renal function, is race-agnostic, extends to heart failure, applies from age 30, and agrees closely with FRS, easing transition. Targeted imaging, including coronary artery calcium scoring, may supplement intermediate-risk candidates. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was reviewed and approved by the University of Texas Medical Branch Institutional Review Board, protocol number 25-0347. It was conducted in accordance with the Declaration of Helsinki. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data that support the findings of this study are available from the corresponding author upon reasonable request. The data are not publicly available due to privacy restrictions on protected health information. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted October 16, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Pre-Deployment Cardiovascular Risk Assessment and Outcomes among United States Antarctic Program Participants: Insights from Contemporary Risk Models Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Pre-Deployment Cardiovascular Risk Assessment and Outcomes among United States Antarctic Program Participants: Insights from Contemporary Risk Models Daniel Paul LeBlanc , Abdul Qadeer , Shiva Raju Gollapally Krishna , Andrew Forrester , Anjni Patel , Daniel Shi , Eric Nagueh , Jeremy Hsu , Neel Bhobe , Diann E. Gaalema , James McKeith , Hani Jneid , Joseph Allencherril medRxiv 2026.10.14.26365580; doi: https://doi.org/10.64898/2026.10.14.26365580 Share This Article: Copy Citation Tools Pre-Deployment Cardiovascular Risk Assessment and Outcomes among United States Antarctic Program Participants: Insights from Contemporary Risk Models Daniel Paul LeBlanc , Abdul Qadeer , Shiva Raju Gollapally Krishna , Andrew Forrester , Anjni Patel , Daniel Shi , Eric Nagueh , Jeremy Hsu , Neel Bhobe , Diann E. Gaalema , James McKeith , Hani Jneid , Joseph Allencherril medRxiv 2026.10.14.26365580; doi: https://doi.org/10.64898/2026.10.14.26365580 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (629) Allergy and Immunology (914) Anesthesia (343) Cardiovascular Medicine (4926) Dentistry and Oral Medicine (488) Dermatology (422) Emergency Medicine (667) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1658) Epidemiology (16131) Forensic Medicine (35) Gastroenterology (1229) Genetic and Genomic Medicine (7175) Geriatric Medicine (740) Health Economics (1081) Health Informatics (5190) Health Policy (1453) Health Systems and Quality Improvement (1810) Hematology (596) HIV/AIDS (1366) Infectious Diseases (except HIV/AIDS) (16403) Intensive Care and Critical Care Medicine (1189) Medical Education (687) Medical Ethics (156) Nephrology (734) Neurology (7450) Nursing (374) Nutrition (1111) Obstetrics and Gynecology (1275) Occupational and Environmental Health (1024) Oncology (3693) Ophthalmology (1077) Orthopedics (400) Otolaryngology (461) Pain Medicine (488) Palliative Medicine (142) Pathology (715) Pediatrics (1838) Pharmacology and Therapeutics (745) Primary Care Research (780) Psychiatry and Clinical Psychology (6043) Public and Global Health (9890) Radiology and Imaging (2482) Rehabilitation Medicine and Physical Therapy (1495) Respiratory Medicine (1260) Rheumatology (655) Sexual and Reproductive Health (792) Sports Medicine (591) Surgery (794) Toxicology (109) Transplantation (314) Urology (300)
## Related Clinical Research

- [Psychosocial profile in adults with congenital heart disease by documented anxiety disorder history](https://medichelpline.com/clinical-feed/plos-one-21-psychosocial-profile-of-adults-with-congenital-heart-disease-according-to.md)
- [Controlling Hypertension Could Avert Over 500,000 Deaths Annually, Analysis Finds](https://medichelpline.com/clinical-feed/medical-news-today-1-over-500-000-deaths-a-year-could-be-prevented-by-managing-blood-pressure.md)
- [Cardiovascular risk prediction models in women: protocol for an updated systematic review](https://medichelpline.com/clinical-feed/plos-one-7-cardiovascular-risk-prediction-models-for-women-a-systematic-review-protocol.md)
- [C-QIP feasibility trial: Multicomponent quality improvement for chronic cardiovascular care in Ind](https://medichelpline.com/clinical-feed/plos-medicine-1-assessing-a-multicomponent-quality-improvement-strategy-for-chronic-care-of.md)
- [Machine-learning prediction of pacing-induced cardiomyopathy in AV block with preserved or mildly](https://medichelpline.com/clinical-feed/medrxiv-11-machine-learning-based-prediction-of-pacing-induced-cardiomyopathy-in-patients.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.